Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1976 May 1;1(6017):1035–1038. doi: 10.1136/bmj.1.6017.1035

Management of early cancer of the breast. Report on an international multicentre trial supported by the Cancer Research Campaign.

PMCID: PMC1639888  PMID: 773497

Abstract

In the largest controlled clinical study so far undertaken on the management of early cancer of the breast in women the results of a radical regimen (simple mastectomy and radiotherapy) were compared with those of a conservative policy (simple mastectomy alone). The study included enough patients (2268) to ensure that small but significant differences between the two treatments would emerge. With a five-year follow-up there was no evidence that routine postoperative radiotherapy was harmful or that it conferred further benefit as regards survival or distant recurrence. Radiotherapy did, however, reduce the incidence of local recurrence. Neither form of treatment can counter occult disease far from the breast that is present at the time of initial treatment, which probably accounts for the high death rate from breast cancer, but the results of the study would support the view that conservative primary treatment and subsequent adjuvant chemotherapy may be the treatment of choice in future.

Full text

PDF
1035

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum M., Edwards M. H., Magarey C. J. Organization of clinical trial on national scale: management of early cancer of the breast. Br Med J. 1972 Nov 25;4(5838):476–478. doi: 10.1136/bmj.4.5838.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boag J. W., Haybittle J. L., Fowler J. F., Emery E. W. The number of patients required in a clinical trial. Br J Radiol. 1971 Feb;44(518):122–125. doi: 10.1259/0007-1285-44-518-122. [DOI] [PubMed] [Google Scholar]
  3. Bonadonna G., Brusamolino E., Valagussa P., Rossi A., Brugnatelli L., Brambilla C., De Lena M., Tancini G., Bajetta E., Musumeci R. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976 Feb 19;294(8):405–410. doi: 10.1056/NEJM197602192940801. [DOI] [PubMed] [Google Scholar]
  4. Brinkley D., Haybrittle J. L. The curability of breast cancer. Lancet. 1975 Jul 19;2(7925):95–97. doi: 10.1016/s0140-6736(75)90003-3. [DOI] [PubMed] [Google Scholar]
  5. Cosimi A. B., Brunstetter F. H., Kemmerer W. T., Miller B. N. Cellular immune competence of breast cancer patients receiving radiotherapy. Arch Surg. 1973 Oct;107(4):531–535. doi: 10.1001/archsurg.1973.01350220015005. [DOI] [PubMed] [Google Scholar]
  6. Fisher B., Carbone P., Economou S. G., Frelick R., Glass A., Lerner H., Redmond C., Zelen M., Band P., Katrych D. L. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med. 1975 Jan 16;292(3):117–122. doi: 10.1056/NEJM197501162920301. [DOI] [PubMed] [Google Scholar]
  7. Magarey C. J., Baum M. Reticulo-endothelial activity in humans with cancer. Br J Surg. 1970 Oct;57(10):748–752. doi: 10.1002/bjs.1800571013. [DOI] [PubMed] [Google Scholar]
  8. Mueller C. B., Jeffries W. Cancer of the breast: Its outcome as measured by the rate of dying and causes of death. Ann Surg. 1975 Sep;182(3):334–341. doi: 10.1097/00000658-197509000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Murray J. G. Cancer Research Campaign breast study. Br J Surg. 1974 Oct;61(10):772–774. doi: 10.1002/bjs.1800611007. [DOI] [PubMed] [Google Scholar]
  10. Pasternack B. S., Gilbert H. S. Planning the duration of long-term survival time studies designed for accrual by cohorts. J Chronic Dis. 1971 Dec;24(11):681–700. doi: 10.1016/0021-9681(71)90094-4. [DOI] [PubMed] [Google Scholar]
  11. Roberts M. M., Blumgart L. H., Davies M., Henk J. M., Forrest A. P., Campbell H., Gleave E. N., Kunkler P. B., Shields R., Hulbert M. Simple versus radical mastectomy. Preliminary report of the Cardiff breast trial. Lancet. 1973 May 19;1(7812):1073–1076. doi: 10.1016/s0140-6736(73)90392-9. [DOI] [PubMed] [Google Scholar]
  12. Stjernswärd J. Immunological changes after radiotherapy for mammary carcinoma. Ann Inst Pasteur (Paris) 1972 Apr;122(4):883–894. [PubMed] [Google Scholar]
  13. Stjernswärd J., Jondal M., Vánky F., Wigzell H., Sealy R. Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet. 1972 Jun 24;1(7765):1352–1356. doi: 10.1016/s0140-6736(72)91091-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES